Sponsored By

Interview with the Innovators

Antibody Drug Conjugate Therapy for the Treatment of HER2+ and HER2-Low mBC

Video Library | November 27, 2023
In this inaugural video, the panel provides peer-to-peer perspectives on educating the care team and patients on the new classification of HER2-low mBC.
Video Library | November 27, 2023
In the third video of this series, knowledgeable advance practice providers contribute their viewpoints on the attributes of targeted antibody drug conjugate therapy for mBC that may help some patients fulfill their treatment goals.
Video Library | November 27, 2023
This video is the fourth in the series where skilled discussants share their approaches to managing patient expectations of treatment and side effects associated with antibody drug conjugate therapy for mBC.
Video Library | November 27, 2023
To conclude this series, our seasoned panel describes how clinical trial and practical experiences with antibody drug conjugate therapy for mBC instill their confidence in this therapy.

Results 1 - 6 of 6

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country